
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)
Keywords: bone marrow; idiopathic pulmonary fibrosis; mesenchymal stem cells; safety trial; 6-MWT; 6-min walk test; Dlco; diffusing capacity of the lungs for carbon monoxide; FDA; Food and Drug Administration; hMSCs; human mesenchymal stem cells; HRCT; high-reso